diip premium nixodine dip pouches on a gray surface pouring out of a dip pouch can
The future of feel-good is here

Meet Nixodine™, our revolutionary, non-nicotine ingredient engineered for a new era. Experience a wave of clean energy, laser-sharp focus, and pure satisfaction that hits right, every time. This is the science behind the flavor. This is the power in your pouch.

What is Nixodine™?

Simply put, Nixodine™ is our secret sauce. It's our revolutionary, non-nicotine ingredient that delivers that satisfying feeling of focus and energy you're looking for, without any of the tobacco or nicotine.

Think of it as the engine that powers the entire diip experience.

white powder formed in the shape of a circle on a white background
The advantage

All the Feel-Good, None of the Guilt: Get that buzz you want with zero nicotine and zero tobacco.

Clean Energy & Focus: Perfect for work, gaming, or just getting through the day.

Tested and Trusted: We've done our homework. Nixodine™ is rigorously tested to be non-carcinogenic and non-mutagenic.

Quality You Can Count On: Made right here in the USA with all-natural, plant-based, food-grade ingredients.

Digital representation of a brain and brain waves with a black background
How it works

Your brain has little receptors that act like docking stations for things that give you a boost. Nixodine™ is designed to fit perfectly into these stations—the same ones nicotine targets—to light you up with a clean wave of energy and clarity.

The result? You feel sharp, motivated, and ready for whatever's next, without the jitters or crash.

The difference

We didn't just want to make an alternative; we wanted to make something smarter. Nixodine™ was specifically engineered to be different. Our science shows it binds less to the one specific receptor in the brain (α6) that is heavily linked to nicotine dependence.

In plain English? It’s designed to give you all the same satisfaction without the baggage.

Iridescent glass heart-shaped object on a neutral background

The History of Nixodine™

The tale of Nixodine™ kicks off in the late 70's, when Big Tobacco faced a firestorm from health authorities over smoking’s hidden dangers. Fearing a crackdown, industry scientists raced to create bold alternatives to keep the spark alive. They cooked up a trove of different compounds, some showing incredible promise in early research, poised to redefine what satisfaction could mean.

The anticipated bans never came, and Big Tobacco swept these groundbreaking compounds under the rug, possibly because they stumbled upon something too good - potentially less habit-forming and more effective. These discoveries were buried, expired, forgotten, and left to gather dust.

Made in the USA
Naturally Sourced
Safely Tested
Made in the USA
Naturally Sourced
Safely Tested
Made in the USA
Naturally Sourced
Safely Tested
Made in the USA
Naturally Sourced
Safely Tested
Made in the USA
Naturally Sourced
Safely Tested
Made in the USA
Naturally Sourced
Safely Tested
Clean Ingredients
Nicotine-free
Tobacco-free
Clean Ingredients
Nicotine-free
Tobacco-free
Clean Ingredients
Nicotine-free
Tobacco-free
Clean Ingredients
Nicotine-free
Tobacco-free
Clean Ingredients
Nicotine-free
Tobacco-free
Clean Ingredients
Nicotine-free
Tobacco-free

Testing Nixodine™

We investigated the relative nAChR activation potential of Nicotinic α4β2, α3β4, and α6/3/β2β3 using an agonist Fluorometric Imaging Plate Reader (FLIPR) assay.

nAChr Activation Study

α4β2

Nicotinic α4β2 receptors have high affinity for nicotine and account for >90% of nicotine binding to brain tissue.

Graph comparing receptor activation normalized to nicotine with nixodine S salt and nicotine on a log scale.

nAChr Activation Study

α3β4

Nicotinic α3β4 receptors are involved in nicotine reward and physical withdrawal.

Graph comparing receptor activation normalized to nicotine with nixodine S salt and nicotine on a log scale.

nAChr Activation Study

α6/3/β2β3

Nicotinic α6/3/β2β3 receptors are involved in nicotine-stimulated dopamine release and may play a role in nicotine dependence.

Graph comparing receptor activation normalized to nicotine with nixodine S salt and nicotine on a log scale.